Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Other/Ovarian Stimulation

Ovarian Stimulation

12

Pipeline Programs↗

18

Active Trials↗

6

Companies Involved↗

Ovarian Stimulation is an emerging landscape with 12 programs across 6 companies. 4 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

46/100

Pipeline Velocity

6/100

Mech. Concentration

67/100

Completion Rate

77/100

Attrition Rate

13/100

Pipeline

Programs by Phase

Preclinical8

Generic Cetrorelix Acetate

Northwest Women's and Children's Hospital, Xi'an, Shaanxi

Gonadotropins Plus Gnrh Antagonists

Fundacion Dexeus

Dydrogesterone

Solvay Pharmaceuticals

Gonadotropin Releasing Hormone Antagonist

Assiut University

Medroxyprogesterone Acetate

Eli Lilly

Phase 1

No programs

Phase 2

No programs

Phase 34

Luveris

Merck & Co.

Progestin

Washington University School of Medicine

Rhfsh+rhlh

Fundación Santiago Dexeus Font

Administration of Letrozole

IVI Madrid

Approved

No programs

Analysis

Trial Status

104

clinical trials

Completed54 · 52%

Unknown status16 · 15%

Recruiting10 · 10%

Terminated10 · 10%

Not yet recruiting5 · 5%

Withdrawn4 · 4%

Other5 · 5%

Clinical Trials

Trial Activity

104 trials

Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity

Recruiting·AART Fertility Clinics LLC·N/A·NCT06839274·100 enrolled

Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders

Recruiting·AART Fertility Clinics LLC·N/A·NCT06572930·150 enrolled

Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF

Recruiting·NNorthwest Women's and Children's Hospital, Xi'an, Shaanxi·N/A·NCT06023602·1,338 enrolled

Efficacy of Micronized Natural Progesterone Vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.

Recruiting·IInstituto Bernabeu·Phase 4·NCT05954962·150 enrolled

PErsonalized Addition of Recombinant LH in Ovarian Stimulation

Recruiting·FFundación Santiago Dexeus Font·Phase 4·NCT04719000·120 enrolled

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

Recruiting·UUniversity Hospital, Ghent·Phase 4·NCT06175832·60 enrolled

Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate

Recruiting·PPAEC General Hospital, Islamabad·Phase 4·NCT07462065·62 enrolled

INTEnsity of ovariaN Stimulation and Embryo Quality

Recruiting·FFundación Santiago Dexeus Font·Phase 4·NCT04983173·110 enrolled

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders

Recruiting·UUniversity Hospital, Ghent·Phase 4·NCT04487925·208 enrolled

Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.

Recruiting·IIVI Madrid·Phase 3·NCT06244745·152 enrolled

Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings

Active, not recruiting· Ferring logo

Ferring·N/A·NCT06561958·1,500 enrolled

Letrozole 5 mg for 10 Days Versus Letrozole 10 mg for 5 Days for Ovarian Stimulation in PCOS

Active, not recruiting·—·N/A·NCT07448272·80 enrolled

PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)

Active, not recruiting·MMỹ Đức Hospital·N/A·NCT06378268·626 enrolled

Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

Not yet recruiting·—·Phase 2·NCT06212102·120 enrolled

FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients

Not yet recruiting·—·Phase 3·NCT06227949·140 enrolled

Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)